A detailed history of Advisor Group Holdings, Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 4,720 shares of JAZZ stock, worth $579,568. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,720
Previous 4,031 17.09%
Holding current value
$579,568
Previous $430,000 22.33%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$100.57 - $116.37 $69,292 - $80,178
689 Added 17.09%
4,720 $526,000
Q2 2024

Aug 13, 2024

SELL
$103.94 - $118.98 $5,612 - $6,424
-54 Reduced 1.32%
4,031 $430,000
Q1 2024

May 10, 2024

SELL
$115.19 - $132.77 $258,025 - $297,404
-2,240 Reduced 35.42%
4,085 $491,000
Q4 2023

Feb 12, 2024

SELL
$114.26 - $136.0 $698,699 - $831,640
-6,115 Reduced 49.16%
6,325 $777,000
Q3 2023

Nov 13, 2023

BUY
$122.0 - $145.31 $184,830 - $220,144
1,515 Added 13.87%
12,440 $1.61 Million
Q2 2023

Aug 21, 2023

SELL
$122.5 - $147.16 $120,540 - $144,805
-984 Reduced 8.26%
10,925 $1.35 Million
Q2 2023

Aug 10, 2023

SELL
$122.5 - $147.16 $39,935 - $47,974
-326 Reduced 2.66%
11,909 $1.48 Million
Q1 2023

May 12, 2023

BUY
$133.98 - $160.47 $183,954 - $220,325
1,373 Added 12.64%
12,235 $1.79 Million
Q4 2022

Feb 10, 2023

BUY
$129.72 - $159.85 $339,477 - $418,327
2,617 Added 31.74%
10,862 $1.73 Million
Q3 2022

Nov 14, 2022

BUY
$126.59 - $161.18 $66,586 - $84,780
526 Added 6.81%
8,245 $1.1 Million
Q2 2022

Aug 10, 2022

BUY
$141.59 - $168.66 $144,846 - $172,539
1,023 Added 15.28%
7,719 $1.21 Million
Q1 2022

May 04, 2022

SELL
$129.64 - $160.7 $58,467 - $72,475
-451 Reduced 6.31%
6,696 $1.04 Million
Q3 2021

Nov 05, 2021

BUY
$128.64 - $184.79 $198,748 - $285,500
1,545 Added 27.58%
7,147 $932,000
Q2 2021

Aug 02, 2021

BUY
$160.2 - $186.42 $305,501 - $355,502
1,907 Added 51.61%
5,602 $996,000
Q1 2021

May 13, 2021

BUY
$150.19 - $173.5 $61,277 - $70,788
408 Added 12.41%
3,695 $608,000
Q4 2020

Feb 10, 2021

SELL
$140.71 - $165.05 $102,577 - $120,321
-729 Reduced 18.15%
3,287 $540,000
Q3 2020

Nov 12, 2020

SELL
$105.46 - $144.13 $116,744 - $159,551
-1,107 Reduced 21.61%
4,016 $571,000
Q2 2020

Aug 14, 2020

SELL
$95.68 - $121.88 $97,976 - $124,805
-1,024 Reduced 16.66%
5,123 $564,000
Q1 2020

May 18, 2020

BUY
$87.74 - $152.74 $539,337 - $938,892
6,147 New
6,147 $618,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.7B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.